Search
TOPIC IN FOCUS
The latest news and developments that advisors need to create meaningful tax planning strategies for clients.
MORE TO EXPLORE
Expert Perspectives is the home to the voices of industry leaders, as they share their expertise and insights directly from the field.
Discover relevant content from across the suite of ALM legal publications
Media & Resources
The new ruling could change the impact of regulations affecting patients, consumers, employers and brokers.
Debate talk about national security and inflation dominated the night, but Medicare and the ACA also came up.
The government plans to bill the drugmakers for the rebates by late 2025, as part of the new Inflation Reduction Act requirement.
The list of Humata backers includes affiliates of the Blues and UnitedHealth.
Prescription drugs and the Affordable Care Act act seem likely to come up. What else?
In some places, the cost of coming into this world is enough to make a baby cry, even more.
Julie Su, the acting DOL secretary, is thinking, carefully, about issues such as private equity ownership and reinsurance.
ERIC told the state to stop trying to regulate self-funded plans' pharmacy benefit managers.
Reporters have accused PBMs of steering patients toward more expensive drugs and extracting hidden fees.
The current plan reporting rules give regulators no way to catch problems, according to Bobby Scott and Mark DeSaulnier.